Navigation Links
West Announces Third Quarter 2009 Results
Date:11/3/2009

d financial schedules and Safe Harbor Statement.

(1) "Adjusted operating profit" and its components and "adjusted diluted earnings per share (EPS)" are defined as reported operating profit and reported diluted EPS excluding the impact of restructuring costs, discrete tax items and certain other significant items, as described below. Management uses adjusted operating profit and adjusted diluted EPS to measure the business and compare operating results to prior periods. Adjusted operating profit and adjusted EPS also are used, together with other measures, to set performance goals for determining payouts under annual and long-term incentive programs. We believe that investors' understanding of our performance is enhanced by disclosing these measures.

The items excluded from adjusted operating profit and adjusted diluted EPS are:

Brazil Tax Amnesty Benefit: During September 2009, we enrolled in a Brazil amnesty program which entitled us to a reduction in certain tax-related penalties, interest and other costs in exchange for our irrevocable declaration of all specified obligations. As these tax-related obligations were previously accrued, the impact was a pre-tax gain of $3.9 million, or $1.7 million after-tax.

Restructuring Charges: During both 2009 and 2008, we incurred restructuring and other related charges as part of our December 2007 plan to align the plant capacity and workforce of our Tech Group with its revised business outlook and as part of a longer-term strategy of focusing the business on proprietary products. The majority of these charges related to severance and other employee benefits and a smaller portion resulted from asset write-offs and other related costs. The restructuring program was substantially completed during the second quarter of 2009.

2008 Contract Settlement Costs (Income): Under a February 2008 agreement reached with our former customer, Ne
'/>"/>

SOURCE West Pharmaceutical Services, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...atson Pharmaceuticals, Inc. (NYSE: WPI ), a lead... confirmed that its subsidiary, Watson Laboratorie...lication (ANDA) with the U.S. Food and Drug Admini...eon tablets prior to the expiration of a patent ow...son,s 8mg ramelteon tablet product is a generic ve...
(Date:12/4/2009)...eal Shore and E. David Crawford presented results ...m the additional analysis of secondary end points ...tal study of FIRMAGON® (monthly degarelix for...er patients during the first year of treatment. P...80 mg/month had a recurrence rate of 7.7% during t...
(Date:12/4/2009)...traZeneca (NYSE: AZN ) today announced that the ... once-daily SEROQUEL XR® (quetiapine fumarate...treatment to antidepressants in adults with Major ... medication in its class approved by the FDA to tr...herapy and acute depressive episodes associated wi...
Breaking Medicine Technology:Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Bird flu leaves the nest adapting to a new host 9699 1Proven Solution for Chinese Drywall is Now Available 55401 1Proven Solution for Chinese Drywall is Now Available 55401 2Hill Rom to Participate at the Thomas Weisel Partners 2009 Healthcare Conference 55399 1Hill Rom to Participate at the Thomas Weisel Partners 2009 Healthcare Conference 55399 2
...stria, July 16 In the clinical phase I trial,AFF0...r patients planned,for this trial. The trial aims ...nnovative Alzheimer,s vaccine (AFFITOPE AD01). In ...t least once and have so far tolerated,the vaccine...accinations,administered at monthly intervals and ...
...Support Phase 2a Clinical Trial at UCSD, NOVATO, ...ptor" or the "Company") (OTC Bulletin Board:,RPTP)... agreement (the,"Agreement") with the University o...e 2a clinical trial to evaluate a delayed-release ...) in adolescents diagnosed with,Non-Alcoholic Stea...
Other Medicine Technology:AFFiRiS: Milestone Reached in Clinical Trial of Alzheimer's Vaccine 2AFFiRiS: Milestone Reached in Clinical Trial of Alzheimer's Vaccine 3Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 2Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 3Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 4Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 5
(Date:12/5/2009)... experts advise , , SATURDAY, Dec. 5 (Heal...th allergies and asthma can have bad reactions to ...l steps to prevent sneezing and wheezing, accordin...mmunology (ACAAI). , Those who are allergic to liv...l plants, but both live and artificial trees can t...
(Date:12/5/2009)...urbines are popping up in the most unusual places,...ng wine to keeping prisoners in jail! , ...ld have thought that your wine, water and vegetabl...f Fort Worth, Texas has announced a new line of tu...Using a technology developed to provide power for ...
(Date:12/4/2009)...ec. 4 Allied World Assurance,Company Holdings, Lt...ani,President and Chief Executive Officer, and Jac...orate Strategy Officer, will be presenting at the ...nce being held at the Goldman,Sachs Conference Cen... ,, About Allied World Assurance Company , ...
(Date:12/4/2009)... Pamela Bowen, Chief Information Officer at Cresce..."Chief Innovation Officer" Appy Award for transfor...omputing. Appy Award recipients are nominated base...he Force.com platform in bringing new levels of cu... service, support or IT organizations. ,, "It is ...
(Date:12/4/2009)...at Johns Hopkins publishing in the December issue ... gene called "Twist" may be the proverbial red fla...drive aggressive, metastatic breast cancer from ot...k suggesting that it is a relatively rare subgroup... cancer, scientists have surmised that this subgro...
Breaking Medicine News(10 mins):Health News:Keep Asthma, Allergies at Bay for the Holidays 2Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3
...d women who consumed higher levels of calcium and ...eater volumes of brain lesions, regions of damage/...dementia, depression and stroke. Dr. Payne ..., 153 women) between the ages of 60 and 86 (averag...
...States the gays prefer to find out whether their p... used rather than use protection to prevent// catc...d sex is a sure way of transmitting the virus, whi...t also proved that many of the volunteers were una...
...rving in the rural areas have had enough. Most Doc... long hours of work//. A survey conducted by the A... doctors are sick of the stress because of the sta...e shortage of doctors. The burden then rests on th...
...rican scientists has added a new weapon of defense...study lead by Dr Qiuying Yang, from the University...al of obstetrics and gynecology -BJOG, has linked ...cies recorded by the US National Center for Health...
... the famous Indian epic, a prince donates his yout...e his passions//. Another kind of help is at h... gene that plays a central role in the ageing proc...that are subjected to a calorie-restricted diet -w...
... was vehemently against his wife’s decision to und...is desire too far//. McCarthy, 27, who belonged t...idnapping his wife, Mrs. McCarthy on 9 February fr...fe from the hospital where she was to get a breast...
Other Medicine News:Health News:Higher Intake of Calcium and Vitamin D Linked With Brain Lesions in Older People 2Health News:Unprotected Sex Among the Gays on the Rise 2Health News:Doctors Warned Against Encouraging Elective Caesareans 2Health News:Doctors Warned Against Encouraging Elective Caesareans 3Health News:Gene Responsible for Ageing Process Discovered – and Calorie Restriction Could Hel 2
...atchet design provides fingertip ratchet disengage...e Series I Instrument program offers state-of-the-...ile, while maintaining strength and durability. Lo...n tight joint spaces. Series I instruments are ava...
...atchet design provides fingertip ratchet disengage...e Series I Instrument program offers state-of-the-...ile, while maintaining strength and durability. Lo...n tight joint spaces. Series I instruments are ava...
Graspers Atraumatic
Basket Punches 90 Rotary
Medicine Products: